MedPath

FETAL MEDICINE FOUNDATION

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
https://fetalmedicine.org/

Clinical Trials

3

Active:0
Completed:2

Trial Phases

2 Phases

Phase 3:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (50.0%)
Phase 3
1 (50.0%)

Effect of Ascorbic Acid Supplementation in Pregnancy on Anemia (AAA)

Not Applicable
Withdrawn
Conditions
Anemia in Pregnancy
First Posted Date
2018-06-21
Last Posted Date
2022-09-22
Lead Sponsor
Fetal Medicine Foundation
Registration Number
NCT03564756
Locations
🇺🇸

Five Rivers Health Centers, Dayton, Ohio, United States

First Trimester Prediction of Preeclampsia and Fetal Growth Restriction

Completed
Conditions
Fetal Growth Restriction
Preeclampsia
First Posted Date
2015-03-05
Last Posted Date
2017-08-22
Lead Sponsor
Fetal Medicine Foundation
Target Recruit Count
1200
Registration Number
NCT02379494
Locations
🇺🇸

Miami Valley Hospital, Dayton, Ohio, United States

Oral Progesterone for Prevention of Preterm Birth

Phase 3
Completed
Conditions
Preterm Birth
Interventions
Drug: Identical Placebo tablet
First Posted Date
2010-08-12
Last Posted Date
2019-02-18
Lead Sponsor
Fetal Medicine Foundation
Target Recruit Count
36
Registration Number
NCT01180296
Locations
🇺🇸

Miami Valley HospitaL, Dayton, Ohio, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.